Literature DB >> 8973279

Growth factors in subglottic stenosis.

K A Scioscia1, F Miller, M M April, B L Gruber.   

Abstract

We sought to define the role of fibrogenic peptides in subglottic stenosis (SGS). Biopsy specimens were obtained from patients with stenosis following endotracheal intubation (group 1, n = 5, mean age 5), patients without a history of any precedent trauma, ie. idiopathic stenosis (group 2, n = 3, mean age 40), and those without stenosis (group 3, n = 3, mean age 70). Formalin-fixed biopsy specimens were analyzed following immunohistochemical staining to determine if epidermal growth factor (EGF), platelet-derived growth factor-AA and -BB (PDGF-AA/BB), transforming growth factor-beta 1 and -beta 2 (TGF-beta 1, beta 2), or basic fibroblast growth factor (bFGF) was deposited in these tissues. Blinded analysis revealed TGF-beta 2 and PDGF-AA to be present in seven of eight biopsy specimens from SGS and absent in controls. Staining for PDGF-BB was observed in the mucosa and submucosa and occasionally within vessel walls. Staining of individual growth factors appeared to correlate closely with the presence of granulation tissue. Essentially no bFGF or TGF-beta 1 was observed. Differences were found between patients in groups 1 and 2; tissue from group 1 revealed deposition of EGF and PDGF-BB in submucosa, epithelium, and vasculature. In summary, our experimental findings implicate PDGF and TGF-beta 2, perhaps acting in concert, in mediating the pathologic fibrotic process observed in subglottic stenosis. Epidermal growth factor, in conjunction with TGF-beta and PDGF, may also have a role, but further investigation is needed to more precisely define it.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973279     DOI: 10.1177/000348949610501202

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  6 in total

1.  Interferon-γ Treatment of Human Laryngotracheal Stenosis-Derived Fibroblasts.

Authors:  Kevin Motz; Idris Samad; Linda X Yin; Michael K Murphy; Madhavi Duvvuri; Dacheng Ding; Alexander T Hillel
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-11-01       Impact factor: 6.223

2.  Persistent Inflammation and Nitric Oxide Dysregulation Are Transcriptomic Blueprints of Subglottic Stenosis.

Authors:  Hoang C B Nguyen; Tiffany N Chao; Noam A Cohen; Natasha Mirza
Journal:  Front Immunol       Date:  2021-12-20       Impact factor: 7.561

Review 3.  Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults.

Authors:  Alessandro Marchioni; Roberto Tonelli; Alessandro Andreani; Gaia Francesca Cappiello; Matteo Fermi; Fabiana Trentacosti; Ivana Castaniere; Riccardo Fantini; Luca Tabbì; Dario Andrisani; Filippo Gozzi; Giulia Bruzzi; Linda Manicardi; Antonio Moretti; Serena Baroncini; Anna Valeria Samarelli; Massimo Pinelli; Giorgio De Santis; Alessandro Stefani; Daniele Marchioni; Francesco Mattioli; Enrico Clini
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

4.  Gastroesophageal Reflux Characteristics and Patterns in Patients with Idiopathic Subglottic Stenosis.

Authors:  Hongfei Fang; Don C Codipilly; Karthik Ravi; Dale C Ekbom; Jan L Kasperbauer; Magnus Halland
Journal:  Gastroenterol Res Pract       Date:  2018-06-11       Impact factor: 2.260

Review 5.  The role of inflammatory cytokines in the development of idiopathic subglottic stenosis.

Authors:  Kevin M Motz; Alexander Gelbard
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

Review 6.  Inflammatory pathways in the pathogenesis of iatrogenic laryngotracheal stenosis: what do we know?

Authors:  Ruth J Davis; Alexander T Hillel
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.